GSTM1 and breast carcinoma: In contrast, Fe and Hb levels were significantly reduced in breast cancer patients compared to controls (80.89 ± 35.8 vs. 95.07 ± 24.02, p < 0.05) and (11.63 ± 1.33 vs. 13.74 ± 0.97, p < 0.05).